Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation. - Wikidata - awgldk - TriplyDB

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation.

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation.

http://www.wikidata.org/entity/Q34435166

about

The metabolic vascular syndrome - guide to an individualized treatment Lipids and the endothelium: bidirectional interactions Renal endothelial dysfunction in diabetic nephropathy Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes Pathogenesis of diabetic cerebral vascular disease complication Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes Oxidative stress and diabetic complications Regulation of obesity and insulin resistance by nitric oxide The endothelial cell: an "early responder" in the development of insulin resistance.Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis.Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.Human glomerular endothelium: interplay among glucose, free fatty acids, angiotensin II, and oxidative stress.Mitochondria, endothelial cell function, and vascular diseases.Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008 A randomized trial of therapies for type 2 diabetes and coronary artery disease A novel high-throughput screening assay for discovery of molecules that increase cellular tetrahydrobiopterin.Postprandial oxidative stress in response to dextrose and lipid meals of differing size.Oxidative stress: implications for the development of diabetic retinopathy and antioxidant therapeutic perspectives.Metabolomic analyses for atherosclerosis, diabetes, and obesity.Lipotoxicity contributes to endothelial dysfunction: a focus on the contribution from ceramide.Chamnamul [Pimpinella brachycarpa (Kom.) Nakai] ameliorates hyperglycemia and improves antioxidant status in mice fed a high-fat, high-sucrose diet Polyphenol fraction of extra virgin olive oil protects against endothelial dysfunction induced by high glucose and free fatty acids through modulation of nitric oxide and endothelin-1.Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation.Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury.Insulin resistance and atherosclerosis.PPARalpha activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans.Prolonged fasting identifies heat shock protein 10 as a Sirtuin 3 substrate: elucidating a new mechanism linking mitochondrial protein acetylation to fatty acid oxidation enzyme folding and function.Role of oxidative stress in endothelial insulin resistance.Urea-induced ROS cause endothelial dysfunction in chronic renal failure Endothelial cell metabolism in normal and diseased vasculature.Pravastatin reverses obesity-induced dysfunction of induced pluripotent stem cell-derived endothelial cells via a nitric oxide-dependent mechanism.Antiobesogenic role of endothelial nitric oxide synthase.Vascular effects of exercise: endothelial adaptations beyond active muscle beds FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis.Insulin resistance, metabolic stress, and atherosclerosis.Mitochondria: redox metabolism and dysfunction.Omega 3 Fatty Acids Supplementation and Oxidative Stress in HIV-Seropositive Patients. A Clinical Trial.GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop Mitochondrial dysfunction and mitochondrial DNA mutations in atherosclerotic complications in diabetes

P2860

Q26767142-ADC05065-C4CB-43BC-B380-CDA83AA256C6 Q26860086-22ED2E6C-CFE1-44CC-B297-D506C6E4C6CD Q27021318-CD2BE6B4-021C-42ED-87AC-CCAA86FD76E3 Q28081462-36DA685A-0A6F-41DB-A4AE-BE55BDA1F4CA Q28087462-2B7B7FF8-711E-417D-9FE1-4EDBAB707257 Q28395675-DECE4E0C-9B92-4F86-9CAA-92158406AF3D Q29615423-CBA1BC7F-B6DA-4048-AF34-5D4AFC8A42D4 Q30363035-BED0B8F5-E103-4D68-93B7-8FCD105F3E6E Q30414637-7CB203AB-483A-4E24-A973-2D281BF0CC80 Q33398039-95B449DD-D502-4B22-9A05-A44A1528DB0E Q33559582-12EF08F5-E3B4-4D84-9582-DC9B6B25311F Q33589138-C61B1DC4-36FC-488F-B9F7-29B9F3F57952 Q33600464-CF03C551-565E-4437-ABD9-1A4FB686D3F6 Q33602366-DA467DAD-DE6D-471A-BBAD-2D31929922F7 Q33827504-6C2A5556-7112-4C6D-ACB0-B3409B6E1284 Q33938854-60353082-9FD3-46D3-B3F1-9AC92A6316FF Q34043832-E4A730E3-2DA2-43BC-90DC-CD1BA0BFBCC7 Q34081808-3611B401-1650-4196-A5D1-6F1D9C5E66FB Q34256164-9111F40D-9BDB-417F-A479-F74EDE5F7F94 Q34269858-F931E631-09EA-41D0-8625-CE050F81F16B Q34393045-62764A60-875D-433F-9D36-AAF7A5AB0A48 Q34432247-3EC60B8B-BA5F-4656-A98F-CBC9E5684EDB Q34485920-8AD16772-726F-4DF6-A27D-01D8D0DC151B Q34509518-E8F52BC5-D97A-4BD4-A814-66B2A07DFBA5 Q34538671-9C130F20-64C4-49E0-AA53-D822F182BB9F Q34698887-6E450DA1-72A5-4249-86B1-24E4CB83D68B Q35000567-17DD0127-EA69-4C80-92B4-E2BB40D8DB92 Q35003024-BD4685E6-8310-4559-BA00-38E45C868927 Q35179243-675F5BA4-3106-481D-A68F-869BCC58F425 Q35181241-81942D64-61FB-484F-98C3-BEAEB03A9D5D Q35234625-FE07544C-3531-434B-BF75-5EFB8E0E1E22 Q35237250-7B56FA10-A877-45B7-976F-E0C6B4F4FDE7 Q35540257-F7F9BBCC-3C19-4AE4-BF64-70986EF26151 Q35776040-275456FA-8E0B-4335-8057-D7BE9DA526B7 Q35861980-F2E75A23-842A-448E-9537-F553F6FA7478 Q35871387-0FD48D70-2D81-4FF3-9B7A-51BB159C865B Q35944831-7C337C5C-E28F-4AE5-A300-F4A4C9A74928 Q35970578-8A40BB8B-43D9-4088-8639-4DDE67F067F1 Q35973918-5A3B6036-80A4-4995-B3DF-7D96003F7447 Q35999426-1B6A5624-7D04-4E11-B98D-4DE38230446C

P2860

Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation.

http://www.wikidata.org/entity/Q34435166

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@ast

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@en

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@nl

type

label

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@ast

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@en

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@nl

prefLabel

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@ast

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@en

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@nl

P1433

Q34435166-4BDE7606-7F41-46A0-AF50-E93952240810

P1476

Q34435166-598CD9C9-C4F4-44C9-9D5E-BDD1CCB35BFA

P2093

Q34435166-1841EA05-6887-494E-8F8A-E9FBE6D2FDFC

Q34435166-40C24288-F4FE-43D9-AD79-606C722AADD4

Q34435166-88A0B0AD-BBE2-487D-992B-69AE9C95360D

Q34435166-A0A881FE-87F0-4FB5-9B54-62BB440A3D99

Q34435166-AFEF0FE6-A98A-42A5-AC3B-F33414DE837C

Q34435166-E7F2B5B6-D345-4A73-8F3B-CE1BC2E46A08

P2860

Q34435166-011252FD-D504-46AB-B07D-55FA47A24C90

Q34435166-01BEFEA8-9D3C-487C-B563-00AB86FAE466

Q34435166-05A9E98E-A9C6-40ED-9E79-79CDFC3D8557

Q34435166-06BBD562-015E-4B82-B9E2-248665CEFE1B

Q34435166-0B52C8BF-B6C5-48E3-B8C8-D152E3AEE4E4

Q34435166-138C2371-2989-49CD-B066-965BA770E843

Q34435166-18D7C427-29F7-4E65-BF6C-EC1F99BDFDEC

Q34435166-20380095-BB58-4EDE-ACD7-BF6F2A9A5E2F

Q34435166-20C5CC75-C314-4C59-A4EB-361B50ABB7E1

Q34435166-2366689D-B90B-4BD9-AE01-B92BEF4CCE74

P304

Q34435166-E4F614FC-960B-423F-8A85-87F19D94D7F8

P31

Q34435166-5D10A679-CB85-4FDB-94DD-5460D9CCFCA6

P356

Q34435166-F32E03D4-9E6F-4FFB-B54B-921D9CCAEBCC

P407

Q34435166-BB071100-9055-4A29-89A3-944C6AB256D0

P433

Q34435166-2726F034-76D0-4BD5-8A2F-883D9F46AC66

P478

Q34435166-131760D9-B90F-4907-A128-A372819C4A02

P577

Q34435166-3ED3290B-7F5B-4F64-ABFE-7ABAE924D2C3

P5875

Q34435166-6449945B-241C-4FD3-95BF-3D4C7DA00451

P698

Q34435166-7F9F94C4-3C7B-4334-ADCC-F206341C54FB

P921

Q34435166-37EE8E8C-0E7C-4CBD-9502-C5447E824598

Q34435166-57D93E17-41E5-4B8D-A7CB-82C2619EF9A9

Q34435166-D6B2852C-0794-41B4-9925-C43FB002B1D5

P932

Q34435166-255D026B-6268-4FD8-9FA1-A892186C89C5

P356

P1433

Journal of Clinical Investigation

P1476

Insulin resistance reduces art ...... othelial fatty acid oxidation.

@en

P2093

Diane Edelstein

http://www.w3.org/2001/XMLSchema#string

Michael Brownlee

http://www.w3.org/2001/XMLSchema#string

Ming-Hui Zou

http://www.w3.org/2001/XMLSchema#string

Ninon Higham

http://www.w3.org/2001/XMLSchema#string

Silvana Obici

http://www.w3.org/2001/XMLSchema#string

Xueliang Du

http://www.w3.org/2001/XMLSchema#string

P2860

Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults

Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

Biochemistry and molecular cell biology of diabetic complications

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease

Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1

Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site

Mechanisms of fatty acid-induced inhibition of glucose uptake

Increased oxidative stress in obesity and its impact on metabolic syndrome

P304

1071-1080

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI23354

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7250776

http://www.w3.org/2001/XMLSchema#string

P698

16528409

http://www.w3.org/2001/XMLSchema#string

P921

P932

1395482

http://www.w3.org/2001/XMLSchema#string